Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study
Résumé
Background: Compared with standard karyotype, chromosomal microarray analysis improves the detection of genetic anomalies and is thus recommended in many prenatal indications. However, evidence is still lacking on the clinical utility of chromosomal microarray analysis in cases of isolated fetal growth restriction.Objective: This study aimed to estimate the proportion of copy number variants detected by chromosomal microarray analysis and the incremental yield of chromosomal microarray analysis compared with karyotype in the detection of genetic abnormalities in fetuses with isolated fetal growth restriction.Study design: This retrospective study included all singleton fetuses diagnosed with fetal growth restriction and no structural ultrasound anomalies and referred to 13 French fetal medicine centers over 1 year in 2016. Fetal growth restriction was defined as an estimated fetal weight of
Origine : Fichiers produits par l'(les) auteur(s)
Accord Elsevier CCSD : Connectez-vous pour contacter le contributeur
https://inserm.hal.science/inserm-03617447
Soumis le : vendredi 5 janvier 2024-16:49:19
Dernière modification le : mardi 23 avril 2024-11:22:11
Dates et versions
Licence
Identifiants
- HAL Id : inserm-03617447 , version 1
- DOI : 10.1016/j.ajog.2021.05.035
- PII : S0002-9378(21)00603-7
- PUBMED : 34058167
- WOS : 000730433700025
Citer
Isabelle Monier, Aline Receveur, Véronique Houfflin-Debarge, Valérie Goua, Vanina Castaigne, et al.. Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study. American Journal of Obstetrics and Gynecology, 2021, 225 (6), pp.676.e1-676.e15. ⟨10.1016/j.ajog.2021.05.035⟩. ⟨inserm-03617447⟩
Collections
49
Consultations
2
Téléchargements